Certolizumab pegol Completed Phase 3 Trials for Rheumatoid Arthritis Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science3
clinicaltrials.gov IdentifierTitleDrugs
NCT01374971Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)